Greenway Reports Strong Q3 Revenue Growth 2026
February 25, 2026 – Kingsville, Ontario, Canada Greenway Greenhouse Cannabis Corporation has reported its financial results for the third...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
February 25, 2026 – Kingsville, Ontario, Canada Greenway Greenhouse Cannabis Corporation has reported its financial results for the third...
MALVERN, Pa., November 4, 2025 — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company advancing soft-tissue reconstruction...
